NORETHINDRONE

NORETHINDRONE was reported 5580 times

NORETHINDRONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BORDERLINE SEROUS TUMOUR OF OVARY 9 0.2903
1 HAEMORRHAGIC TUMOUR NECROSIS 5 0.1064
2 BORDERLINE OVARIAN TUMOUR 7 0.1045
3 HEPATIC ADENOMA 43 0.0832
4 METAPLASIA 24 0.0508
5 DENTAL PARAESTHESIA 3 0.0492
6 NASAL MUCOSAL DISCOLOURATION 6 0.0373
7 ADNEXAL TORSION 11 0.0347
8 ENDOMETRIOSIS 144 0.0302
9 PELIOSIS HEPATIS 4 0.0278
10 LAPAROSCOPY 7 0.0266
11 DILATATION INTRAHEPATIC DUCT ACQUIRED 7 0.0240
12 ADNEXA UTERI PAIN 29 0.0227
13 MENSTRUATION NORMAL 6 0.0181
14 HEPATIC RUPTURE 4 0.0179
15 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 3 0.0170
16 UTERINE PAIN 17 0.0166
17 UTERINE CYST 9 0.0158
18 EXPOSURE TO ALLERGEN 5 0.0157
19 SUPPRESSED LACTATION 11 0.0146
20 CONTRALATERAL BREAST CANCER 3 0.0146
21 CEREBRAL FUNGAL INFECTION 4 0.0141
22 CEREBRAL VENOUS SINUS THROMBOSIS 11 0.0130
23 HEPATIC ISCHAEMIA 4 0.0129
24 ENDOMETRIAL ABLATION 4 0.0112
25 SUPERIOR SAGITTAL SINUS THROMBOSIS 8 0.0100
26 PELVIC PAIN 181 0.0100
27 MENSTRUAL DISORDER 82 0.0099
28 PERIORBITAL CELLULITIS 5 0.0093
29 ENDOMETRIAL THICKENING 5 0.0090
30 UTERINE ENLARGEMENT 7 0.0088
31 HAEMORRHAGIC OVARIAN CYST 5 0.0087
32 BLOOD OESTROGEN DECREASED 6 0.0085
33 ADENOMYOSIS 5 0.0085
34 MENORRHAGIA 165 0.0084
35 UTERINE SPASM 15 0.0082
36 PREGNANCY ON ORAL CONTRACEPTIVE 21 0.0080
37 INTERMENSTRUAL BLEEDING 44 0.0079
38 POST-TRAUMATIC NECK SYNDROME 6 0.0074
39 VULVOVAGINAL DRYNESS 23 0.0071
40 METRORRHAGIA 117 0.0069
41 UTERINE HAEMORRHAGE 29 0.0068
42 DYSMENORRHOEA 90 0.0068
43 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 4 0.0068
44 OOPHORECTOMY 6 0.0067
45 SOFT TISSUE INJURY 5 0.0066
46 ABNORMAL WITHDRAWAL BLEEDING 6 0.0065
47 VAGINAL HAEMORRHAGE 281 0.0065
48 UTERINE LEIOMYOMA 47 0.0064
49 POLYMENORRHOEA 22 0.0063
50 CORONARY ARTERY DISSECTION 5 0.0058
51 STERNAL FRACTURE 7 0.0057
52 HEAVY MENSTRUAL BLEEDING 51 0.0057
53 OVARIAN CYST 55 0.0055
54 WITHDRAWAL BLEED 4 0.0055
55 APLASTIC ANAEMIA 28 0.0054
56 ADHESION 8 0.0053
57 COLON INJURY 3 0.0052
58 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 7 0.0052
59 INFUSION SITE DISCHARGE 9 0.0051
60 BACTERIAL VAGINOSIS 8 0.0051
61 HOT FLUSH 372 0.0049
62 MOOD SWINGS 156 0.0049
63 LOWER RESPIRATORY TRACT CONGESTION 8 0.0047
64 ABNORMAL UTERINE BLEEDING 12 0.0047
65 DYSPAREUNIA 21 0.0046
66 PREMENSTRUAL SYNDROME 6 0.0044
67 ARNOLD-CHIARI MALFORMATION 4 0.0042
68 PROSTATIC DISORDER 23 0.0042
69 TYMPANIC MEMBRANE PERFORATION 7 0.0041
70 OBSTRUCTIVE SLEEP APNOEA SYNDROME 6 0.0041
71 CEREBRAL VASOCONSTRICTION 3 0.0041
72 DISLOCATION OF VERTEBRA 9 0.0039
73 BREAST ABSCESS 4 0.0039
74 UTERINE POLYP 7 0.0039
75 BREAST FEEDING 3 0.0038
76 WISDOM TEETH REMOVAL 5 0.0038
77 MENOMETRORRHAGIA 7 0.0037
78 OLIGOMENORRHOEA 8 0.0037
79 HEREDITARY ANGIOEDEMA 39 0.0036
80 PRODUCT ADMINISTRATION INTERRUPTED 27 0.0034
81 PREGNANCY ON CONTRACEPTIVE 5 0.0034
82 MENSTRUATION IRREGULAR 90 0.0034
83 PITUITARY TUMOUR 5 0.0034
84 LARGE INTESTINE INFECTION 4 0.0033
85 BLOOD ALKALINE PHOSPHATASE DECREASED 3 0.0032
86 GLUCOSE URINE PRESENT 4 0.0031
87 OVARIAN CYST RUPTURED 4 0.0031
88 GESTATIONAL HYPERTENSION 4 0.0031
89 STRIDOR 9 0.0031
90 PURPURA 27 0.0030
91 AMENORRHOEA 53 0.0030
92 VENA CAVA THROMBOSIS 5 0.0030
93 LIBIDO INCREASED 6 0.0030
94 MATERNAL EXPOSURE DURING BREAST FEEDING 12 0.0030
95 NIGHT SWEATS 95 0.0029
96 BILIARY DYSKINESIA 5 0.0029
97 HYPOMENORRHOEA 8 0.0029
98 PORPHYRIA ACUTE 4 0.0028
99 HYSTERECTOMY 24 0.0028
100 CEREBRAL VENOUS THROMBOSIS 5 0.0028
101 MENOPAUSE 7 0.0027
102 CHOLECYSTITIS CHRONIC 18 0.0027
103 CATHETER SITE DISCHARGE 3 0.0027
104 STEROID DIABETES 4 0.0027
105 BREAST TENDERNESS 20 0.0027
106 ECTOPIC PREGNANCY 8 0.0026
107 MENOPAUSAL SYMPTOMS 6 0.0026
108 VAGINAL DISCHARGE 25 0.0025
109 BREAST DISORDER 5 0.0024
110 PAPILLOMA VIRAL INFECTION 4 0.0024
111 BLOOD UREA DECREASED 3 0.0024
112 EXPOSURE DURING BREAST FEEDING 8 0.0024
113 BLADDER DISCOMFORT 3 0.0024
114 VULVOVAGINAL PRURITUS 12 0.0024
115 TERMINAL INSOMNIA 4 0.0023
116 HORMONE LEVEL ABNORMAL 11 0.0023
117 PRE-EXISTING CONDITION IMPROVED 14 0.0022
118 INFUSION SITE PRURITUS 7 0.0022
119 MONOPARESIS 4 0.0022
120 MIGRAINE 211 0.0022
121 INFUSION SITE INFECTION 5 0.0021
122 RESPIRATORY TRACT INFECTION VIRAL 5 0.0021
123 APPENDIX DISORDER 3 0.0021
124 CATAPLEXY 3 0.0021
125 SINUS OPERATION 5 0.0021
126 INFUSION SITE SWELLING 13 0.0021
127 MOOD ALTERED 56 0.0021
128 DEPRESSION SUICIDAL 7 0.0020
129 URINE ANALYSIS ABNORMAL 6 0.0020
130 HOSTILITY 5 0.0020
131 APPENDICECTOMY 7 0.0020
132 BLOOD IRON DECREASED 23 0.0019
133 PERSONALITY DISORDER 5 0.0019
134 EAR SWELLING 4 0.0019
135 VULVOVAGINAL PAIN 9 0.0019
136 CYSTITIS INTERSTITIAL 3 0.0019
137 BREAST SWELLING 5 0.0019
138 MIGRAINE WITH AURA 5 0.0018
139 INFUSION SITE HAEMORRHAGE 6 0.0018
140 VENOOCCLUSIVE LIVER DISEASE 9 0.0018
141 OTITIS MEDIA 6 0.0018
142 FLAT AFFECT 4 0.0017
143 UTERINE DISORDER 4 0.0017
144 THERAPEUTIC REACTION TIME DECREASED 5 0.0017
145 PROCTALGIA 11 0.0017
146 CRYING 62 0.0017
147 PRODUCT SUPPLY ISSUE 12 0.0017
148 BREAST CANCER METASTATIC 18 0.0017
149 MENSTRUATION DELAYED 18 0.0017
150 SPONDYLITIS 6 0.0016
151 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
152 TRANSFUSION 17 0.0016
153 INTRACRANIAL PRESSURE INCREASED 9 0.0016
154 BLADDER SPASM 3 0.0016
155 BLOOD BLISTER 5 0.0016
156 BLOOD IRON INCREASED 3 0.0016
157 LIGAMENT RUPTURE 7 0.0016
158 TROPONIN INCREASED 12 0.0016
159 ARTERIAL THROMBOSIS 3 0.0016
160 DRUG TITRATION ERROR 4 0.0015
161 MUCORMYCOSIS 4 0.0015
162 POSTMENOPAUSAL HAEMORRHAGE 4 0.0015
163 NEPHROGENIC ANAEMIA 7 0.0015
164 EXPOSURE VIA BREAST MILK 6 0.0015
165 INSURANCE ISSUE 23 0.0015
166 BREAST PAIN 16 0.0015
167 DEEP VEIN THROMBOSIS POSTOPERATIVE 3 0.0015
168 BREAST MASS 10 0.0015
169 VAGINAL INFECTION 7 0.0015
170 INFUSION SITE PAIN 19 0.0015
171 IMPAIRED GASTRIC EMPTYING 20 0.0015
172 MATERNAL EXPOSURE BEFORE PREGNANCY 10 0.0015
173 BODY TEMPERATURE FLUCTUATION 3 0.0014
174 RASH MACULO-PAPULAR 32 0.0014
175 INFUSION SITE ERYTHEMA 12 0.0014
176 CONCUSSION 11 0.0014
177 SKIN HYPERPIGMENTATION 12 0.0014
178 MIDDLE INSOMNIA 26 0.0014
179 ABDOMINAL PAIN LOWER 35 0.0014
180 CERVICAL DYSPLASIA 3 0.0014
181 THORACIC VERTEBRAL FRACTURE 4 0.0014
182 MATERNAL EXPOSURE TIMING UNSPECIFIED 5 0.0013
183 FOOD CRAVING 7 0.0013
184 COELIAC DISEASE 13 0.0013
185 DERMATITIS CONTACT 15 0.0013
186 FOOD POISONING 7 0.0013
187 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
188 BRUXISM 7 0.0013
189 EMOTIONAL DISORDER 40 0.0013
190 BLEPHARITIS 5 0.0012
191 PORTAL VEIN THROMBOSIS 4 0.0012
192 ENURESIS 5 0.0012
193 SPINAL FUSION SURGERY 5 0.0012
194 PERIPHERAL VENOUS DISEASE 5 0.0012
195 BREAST ENLARGEMENT 4 0.0012
196 CYST 15 0.0012
197 ABDOMINAL PAIN 279 0.0012
198 ANXIETY DISORDER 4 0.0012
199 ABDOMINAL INFECTION 3 0.0012
200 ABDOMINAL DISTENSION 122 0.0012
201 CATHETER SITE PAIN 3 0.0012
202 SENSITIVITY TO WEATHER CHANGE 6 0.0011
203 ERYTHEMA NODOSUM 4 0.0011
204 MELAENA 25 0.0011
205 INTERCEPTED PRODUCT STORAGE ERROR 4 0.0011
206 ABDOMINAL MASS 3 0.0011
207 EMBEDDED DEVICE 11 0.0011
208 PHARYNGITIS STREPTOCOCCAL 12 0.0011
209 NORMAL NEWBORN 6 0.0011
210 PREGNANCY 22 0.0011
211 DEVICE KINK 4 0.0011
212 HAEMOGLOBIN INCREASED 5 0.0011
213 ARTHROPOD BITE 8 0.0011
214 ROSACEA 5 0.0011
215 PANIC ATTACK 39 0.0011
216 POLYP 7 0.0011
217 UTERINE PERFORATION 9 0.0011
218 PAROSMIA 8 0.0011
219 SEASONAL ALLERGY 15 0.0011
220 CEREBRAL THROMBOSIS 3 0.0011
221 SNORING 4 0.0011
222 PARANASAL SINUS DISCOMFORT 4 0.0011
223 AFFECT LABILITY 10 0.0010
224 HYPERVENTILATION 6 0.0010
225 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 7 0.0010
226 VENOUS THROMBOSIS 4 0.0010
227 OESOPHAGEAL PAIN 4 0.0010
228 SINUS HEADACHE 6 0.0010
229 MUCOUS STOOLS 5 0.0010
230 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
231 ANGER 34 0.0010
232 PAPULE 7 0.0010
233 VULVOVAGINAL BURNING SENSATION 6 0.0010
234 EAR INFECTION 26 0.0010
235 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
236 RASH ERYTHEMATOUS 46 0.0010
237 FLANK PAIN 9 0.0010
238 DRUG-INDUCED LIVER INJURY 30 0.0010
239 GALLBLADDER DISORDER 17 0.0010
240 ACUTE HEPATIC FAILURE 13 0.0010
241 BLADDER PAIN 3 0.0009
242 GASTROENTERITIS VIRAL 17 0.0009
243 FOREIGN BODY SENSATION IN EYES 6 0.0009
244 HUNGER 13 0.0009
245 GENITAL HAEMORRHAGE 12 0.0009
246 IRRITABILITY 56 0.0009
247 OVERWEIGHT 5 0.0009
248 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
249 ABORTION SPONTANEOUS 37 0.0009
250 NONSPECIFIC REACTION 5 0.0009
251 LIGAMENT SPRAIN 9 0.0009
252 VULVOVAGINAL DISCOMFORT 4 0.0009
253 NEURALGIA 22 0.0009
254 CYSTIC FIBROSIS 5 0.0009
255 DEPRESSION 205 0.0009
256 STREPTOCOCCAL INFECTION 5 0.0009
257 BRAIN FOG 14 0.0009
258 BREAST CANCER 83 0.0009
259 ACNE 67 0.0009
260 TACHYPNOEA 12 0.0009
261 POOR QUALITY SLEEP 19 0.0009
262 INTENTIONAL DOSE OMISSION 25 0.0009
263 CHOLECYSTECTOMY 10 0.0009
264 APLASIA PURE RED CELL 3 0.0009
265 HYPOAESTHESIA ORAL 13 0.0009
266 RECTAL HAEMORRHAGE 37 0.0009
267 DEFAECATION URGENCY 6 0.0009
268 UMBILICAL HERNIA 4 0.0009
269 DEPRESSIVE SYMPTOM 3 0.0009
270 THROAT TIGHTNESS 23 0.0008
271 ABORTION INDUCED 8 0.0008
272 PRE-ECLAMPSIA 4 0.0008
273 CHOLECYSTITIS 10 0.0008
274 SLEEP APNOEA SYNDROME 16 0.0008
275 INCREASED APPETITE 16 0.0008
276 HYPOVOLAEMIC SHOCK 4 0.0008
277 SENSATION OF FOREIGN BODY 7 0.0008
278 BURSITIS 10 0.0008
279 MAJOR DEPRESSION 6 0.0008
280 BLOOD PHOSPHORUS DECREASED 3 0.0008
281 VITAMIN D DECREASED 7 0.0008
282 GASTROINTESTINAL PAIN 9 0.0008
283 WEIGHT INCREASED 183 0.0008
284 KIDNEY INFECTION 16 0.0008
285 HAEMORRHAGE 85 0.0008
286 PRODUCT DOSE OMISSION IN ERROR 23 0.0008
287 MUSCLE SPASMS 148 0.0008
288 ABDOMINAL TENDERNESS 4 0.0008
289 INFUSION SITE EXTRAVASATION 5 0.0008
290 MUSCLE TIGHTNESS 13 0.0008
291 PROTEIN URINE PRESENT 4 0.0008
292 MUCOSAL INFLAMMATION 21 0.0008
293 UPPER RESPIRATORY TRACT INFECTION 37 0.0008
294 FISTULA 9 0.0008
295 COLD SWEAT 14 0.0008
296 CATHETER SITE INFECTION 3 0.0008
297 TOOTH ABSCESS 8 0.0008
298 SCREAMING 5 0.0008
299 WEIGHT LOSS POOR 4 0.0008
300 VIRAL INFECTION 26 0.0008
301 DIFFUSE LARGE B-CELL LYMPHOMA 6 0.0008
302 ANXIETY 221 0.0008
303 MADAROSIS 9 0.0008
304 APHTHOUS ULCER 6 0.0008
305 POOR VENOUS ACCESS 8 0.0008
306 HERPES SIMPLEX 5 0.0008
307 PALPITATIONS 90 0.0008
308 CERVIX CARCINOMA 3 0.0008
309 TENDERNESS 8 0.0008
310 MULTIPLE ALLERGIES 6 0.0008
311 CHOLELITHIASIS 25 0.0008
312 INCREASED TENDENCY TO BRUISE 7 0.0008
313 PRODUCT FORMULATION ISSUE 5 0.0008
314 HYPOAESTHESIA 113 0.0008
315 GINGIVAL PAIN 6 0.0008
316 FUNGAL INFECTION 25 0.0007
317 ANAL FISTULA 4 0.0007
318 ARTERIOSPASM CORONARY 3 0.0007
319 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
320 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
321 ANAL FISSURE 4 0.0007
322 SENSORY LOSS 6 0.0007
323 CYSTITIS HAEMORRHAGIC 3 0.0007
324 FRUSTRATION TOLERANCE DECREASED 6 0.0007
325 COLITIS ISCHAEMIC 5 0.0007
326 WRONG PRODUCT ADMINISTERED 5 0.0007
327 SPINAL DISORDER 7 0.0007
328 UVEITIS 10 0.0007
329 FEELING JITTERY 14 0.0007
330 FEELING HOT 45 0.0007
331 EYE MOVEMENT DISORDER 5 0.0007
332 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
333 INTESTINAL ISCHAEMIA 4 0.0007
334 HEADACHE 455 0.0007
335 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
336 FOOT DEFORMITY 8 0.0007
337 HEPATOMEGALY 7 0.0007
338 PREMATURE LABOUR 4 0.0007
339 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12 0.0007
340 CHOLECYSTITIS ACUTE 4 0.0007
341 IMPAIRED WORK ABILITY 15 0.0007
342 BACK PAIN 162 0.0007
343 BACTERIAL INFECTION 13 0.0007
344 MATERNAL EXPOSURE DURING PREGNANCY 62 0.0007
345 IMPAIRED QUALITY OF LIFE 10 0.0007
346 INSOMNIA 184 0.0007
347 PROCEDURAL PAIN 19 0.0007
348 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
349 INITIAL INSOMNIA 7 0.0007
350 SARS-COV-2 TEST POSITIVE 9 0.0007
351 ABDOMINAL ABSCESS 3 0.0007
352 SENSITIVE SKIN 5 0.0007
353 PRODUCT SUBSTITUTION ISSUE 39 0.0007
354 SUICIDAL IDEATION 62 0.0007
355 POST PROCEDURAL COMPLICATION 13 0.0007
356 MEDICAL DEVICE COMPLICATION 5 0.0007
357 PRESCRIBED OVERDOSE 13 0.0007
358 FOREIGN BODY IN REPRODUCTIVE TRACT 6 0.0007
359 SUNBURN 5 0.0007
360 ODYNOPHAGIA 4 0.0007
361 MYOSITIS 6 0.0007
362 SYMPTOM RECURRENCE 4 0.0007
363 ANAL INCONTINENCE 6 0.0007
364 DEVICE DISLOCATION 29 0.0007
365 SURGERY 39 0.0007
366 NASAL CONGESTION 39 0.0007
367 NECK PAIN 37 0.0007
368 LACRIMATION INCREASED 20 0.0007
369 EXPOSURE DURING PREGNANCY 41 0.0007
370 EXOSTOSIS 6 0.0007
371 TENSION 4 0.0007
372 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
373 ABNORMAL DREAMS 18 0.0007
374 ILLNESS 67 0.0006
375 IRON DEFICIENCY ANAEMIA 6 0.0006
376 DEVICE RELATED INFECTION 10 0.0006
377 FOOD ALLERGY 5 0.0006
378 GASTROOESOPHAGEAL REFLUX DISEASE 52 0.0006
379 TENDONITIS 10 0.0006
380 SCOLIOSIS 4 0.0006
381 THINKING ABNORMAL 12 0.0006
382 DEPRESSED MOOD 34 0.0006
383 TOOTH EXTRACTION 8 0.0006
384 APPENDICITIS 6 0.0006
385 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
386 DEVICE OCCLUSION 9 0.0006
387 BODY TEMPERATURE INCREASED 13 0.0006
388 SWELLING OF EYELID 4 0.0006
389 HYPERHIDROSIS 82 0.0006
390 AFFECTIVE DISORDER 5 0.0006
391 NIGHTMARE 22 0.0006
392 PAIN IN JAW 18 0.0006
393 SINUSITIS 65 0.0006
394 PULMONARY EMBOLISM 60 0.0006
395 THERAPEUTIC RESPONSE CHANGED 4 0.0006
396 DISEASE RECURRENCE 30 0.0006
397 FLUID RETENTION 32 0.0006
398 HEPATOTOXICITY 14 0.0006
399 SCIATICA 10 0.0006
400 ABDOMINAL PAIN UPPER 129 0.0006
401 PRODUCT DOSE OMISSION ISSUE 184 0.0006
402 SKIN INFECTION 7 0.0006
403 HEAD DISCOMFORT 11 0.0006
404 COMPLICATION ASSOCIATED WITH DEVICE 9 0.0006
405 MEMORY IMPAIRMENT 85 0.0006
406 AUTOIMMUNE DISORDER 6 0.0006
407 BONE PAIN 36 0.0006
408 SHOCK HAEMORRHAGIC 5 0.0006
409 SOMNAMBULISM 4 0.0006
410 NAUSEA 482 0.0006
411 STAPHYLOCOCCAL INFECTION 20 0.0006
412 LIVER FUNCTION TEST INCREASED 13 0.0006
413 ALANINE AMINOTRANSFERASE INCREASED 37 0.0006
414 POST-TRAUMATIC STRESS DISORDER 4 0.0006
415 ALOPECIA 117 0.0006
416 SKIN PLAQUE 5 0.0006
417 CANDIDA INFECTION 10 0.0006
418 SINUS CONGESTION 8 0.0006
419 BACTERAEMIA 7 0.0006
420 PRODUCT LABEL ISSUE 4 0.0006
421 SWELLING 55 0.0006
422 NEUTROPHIL COUNT INCREASED 6 0.0006
423 HELICOBACTER INFECTION 6 0.0006
424 ARTHRALGIA 241 0.0006
425 AUTOIMMUNE HEPATITIS 4 0.0006
426 FEELING COLD 16 0.0006
427 ROAD TRAFFIC ACCIDENT 24 0.0006
428 PRODUCT ODOUR ABNORMAL 6 0.0006
429 FEBRILE NEUTROPENIA 38 0.0006
430 FOLLICULITIS 6 0.0006
431 URINE OUTPUT DECREASED 5 0.0006
432 BLOOD LACTIC ACID INCREASED 3 0.0006
433 DERMATITIS ATOPIC 30 0.0006
434 ABDOMINAL DISCOMFORT 95 0.0006
435 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 31 0.0006
436 THERAPY CESSATION 29 0.0006
437 ANORECTAL DISCOMFORT 3 0.0006
438 PHARYNGITIS 7 0.0006
439 RETCHING 12 0.0006
440 FACIAL PAIN 5 0.0006
441 ANAL ABSCESS 3 0.0006
442 DISTURBANCE IN ATTENTION 30 0.0006
443 OROPHARYNGEAL DISCOMFORT 5 0.0006
444 COVID-19 97 0.0006
445 COMPLICATION OF DEVICE INSERTION 11 0.0006
446 SLEEP DISORDER 39 0.0006
447 BIPOLAR DISORDER 6 0.0006
448 POLLAKIURIA 23 0.0006
449 LUPUS-LIKE SYNDROME 5 0.0006
450 FLUSHING 56 0.0006
451 OPTIC NEURITIS 5 0.0005
452 END STAGE RENAL DISEASE 10 0.0005
453 HIDRADENITIS 5 0.0005
454 WOUND INFECTION 6 0.0005
455 INFLUENZA 61 0.0005
456 FEELING ABNORMAL 131 0.0005
457 TOOTH FRACTURE 6 0.0005
458 HYPOPHOSPHATAEMIA 4 0.0005
459 CEREBRAL DISORDER 4 0.0005
460 COAGULOPATHY 9 0.0005
461 PRODUCT DISTRIBUTION ISSUE 5 0.0005
462 FIBROMYALGIA 13 0.0005
463 THROMBOSIS 43 0.0005
464 PHOTOPHOBIA 10 0.0005
465 HEMIPARESIS 9 0.0005
466 TOOTH INFECTION 7 0.0005
467 PAIN 324 0.0005
468 INJURY 37 0.0005
469 ABASIA 13 0.0005
470 DEEP VEIN THROMBOSIS 34 0.0005
471 DISSOCIATION 4 0.0005
472 HAEMOGLOBIN DECREASED 53 0.0005
473 PARAESTHESIA 81 0.0005
474 HEART RATE INCREASED 51 0.0005
475 EAR PAIN 10 0.0005
476 BRONCHITIS 38 0.0005
477 VITAMIN D DEFICIENCY 5 0.0005
478 PULMONARY HAEMORRHAGE 4 0.0005
479 HYPOXIA 18 0.0005
480 PHARYNGEAL SWELLING 5 0.0005
481 SEIZURE 59 0.0005
482 GASTROINTESTINAL INFLAMMATION 4 0.0005
483 PERIPHERAL COLDNESS 7 0.0005
484 CYANOSIS 8 0.0005
485 LYMPHADENOPATHY 18 0.0005
486 PRODUCT DISPENSING ERROR 11 0.0005
487 FURUNCLE 4 0.0005
488 PNEUMOTHORAX 8 0.0005
489 RESPIRATORY TRACT CONGESTION 8 0.0005
490 HYPERLIPIDAEMIA 6 0.0005
491 ABSCESS 8 0.0005
492 MASS 7 0.0005
493 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
494 RESTLESS LEGS SYNDROME 9 0.0005
495 NOCTURIA 6 0.0005
496 GASTRITIS 13 0.0005
497 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
498 DECUBITUS ULCER 4 0.0005
499 RASH PAPULAR 11 0.0005
500 DYSURIA 18 0.0005
501 NASOPHARYNGITIS 90 0.0005
502 PRODUCT USE IN UNAPPROVED INDICATION 121 0.0005
503 DYSPEPSIA 48 0.0005
504 SPINAL OPERATION 6 0.0005
505 HEART RATE IRREGULAR 11 0.0005
506 EYE IRRITATION 28 0.0005
507 MUSCLE INJURY 4 0.0005
508 HEMIPLEGIA 4 0.0005
509 ABNORMAL BEHAVIOUR 19 0.0005
510 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
511 LIVE BIRTH 4 0.0005
512 ATRIAL SEPTAL DEFECT 4 0.0005
513 BLEPHAROSPASM 3 0.0005
514 VOMITING 224 0.0005
515 VERTIGO 29 0.0005
516 INJECTION SITE DISCOMFORT 5 0.0005
517 DISCOMFORT 29 0.0005
518 CHEST PAIN 88 0.0005
519 JOINT DISLOCATION 5 0.0005
520 INJECTION SITE IRRITATION 6 0.0005
521 SCAR 8 0.0005
522 ROTATOR CUFF SYNDROME 6 0.0005
523 DIZZINESS 233 0.0005
524 IRRITABLE BOWEL SYNDROME 10 0.0005
525 CARDIAC FLUTTER 3 0.0005
526 BREAST CANCER STAGE III 3 0.0005
527 MUSCLE STRAIN 4 0.0005
528 DIPLOPIA 12 0.0005
529 PYELONEPHRITIS 4 0.0005
530 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
531 TACHYCARDIA 41 0.0005
532 ORAL HERPES 9 0.0005
533 SWELLING FACE 30 0.0005
534 SKIN LACERATION 5 0.0005
535 MENTAL DISORDER 20 0.0005
536 BRADYPHRENIA 3 0.0005
537 SEDATION 12 0.0005
538 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
539 BEDRIDDEN 6 0.0005
540 PHARYNGEAL OEDEMA 7 0.0005
541 INJECTION SITE NODULE 5 0.0005
542 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
543 FATIGUE 352 0.0005
544 BLOOD PRESSURE DECREASED 30 0.0005
545 VENTRICULAR FIBRILLATION 5 0.0004
546 THIRST 8 0.0004
547 GASTROINTESTINAL INFECTION 4 0.0004
548 FEAR 12 0.0004
549 SNEEZING 10 0.0004
550 OCULAR DISCOMFORT 5 0.0004
551 LOSS OF LIBIDO 4 0.0004
552 BLOOD BILIRUBIN INCREASED 12 0.0004
553 PRODUCT TASTE ABNORMAL 6 0.0004
554 CHROMATURIA 10 0.0004
555 COMPLICATION OF DEVICE REMOVAL 8 0.0004
556 URTICARIA 74 0.0004
557 MYALGIA 75 0.0004
558 CHEST DISCOMFORT 45 0.0004
559 MUSCULOSKELETAL PAIN 23 0.0004
560 BLOOD PRESSURE INCREASED 67 0.0004
561 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 31 0.0004
562 BRAIN NEOPLASM 4 0.0004
563 UROSEPSIS 4 0.0004
564 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
565 HYPOPHAGIA 11 0.0004
566 CAESAREAN SECTION 5 0.0004
567 PRODUCT DOSE OMISSION 28 0.0004
568 CARPAL TUNNEL SYNDROME 6 0.0004
569 EPISTAXIS 32 0.0004
570 DYSPNOEA EXERTIONAL 16 0.0004
571 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
572 BLOOD URINE PRESENT 8 0.0004
573 PRODUCT PACKAGING ISSUE 4 0.0004
574 MULTIPLE SCLEROSIS 20 0.0004
575 PANCREATITIS 22 0.0004
576 SWOLLEN TONGUE 13 0.0004
577 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 75 0.0004
578 HYPERTHYROIDISM 6 0.0004
579 PAIN IN EXTREMITY 122 0.0004
580 ERUCTATION 8 0.0004
581 PRODUCT PRESCRIBING ISSUE 9 0.0004
582 GASTROINTESTINAL DISORDER 37 0.0004
583 CHOKING 8 0.0004
584 TREMOR 68 0.0004
585 SKIN FISSURES 8 0.0004
586 EYE PAIN 23 0.0004
587 INJECTION SITE PAIN 125 0.0004
588 FREQUENT BOWEL MOVEMENTS 11 0.0004
589 DRY MOUTH 33 0.0004
590 MUSCULOSKELETAL DISCOMFORT 7 0.0004
591 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
592 PALLOR 11 0.0004
593 BLADDER DISORDER 4 0.0004
594 INABILITY TO AFFORD MEDICATION 4 0.0004
595 COLITIS ULCERATIVE 18 0.0004
596 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
597 TREATMENT NONCOMPLIANCE 22 0.0004
598 LOCAL SWELLING 7 0.0004
599 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
600 THROAT IRRITATION 18 0.0004
601 INJECTION SITE BRUISING 32 0.0004
602 INFLUENZA LIKE ILLNESS 33 0.0004
603 ADVERSE DRUG REACTION 36 0.0004
604 DRY EYE 20 0.0004
605 VISION BLURRED 55 0.0004
606 THERAPY NON-RESPONDER 18 0.0004
607 SECRETION DISCHARGE 5 0.0004
608 BONE LOSS 6 0.0004
609 ASTHMA 45 0.0004
610 PRODUCTIVE COUGH 19 0.0004
611 PRODUCT PHYSICAL ISSUE 8 0.0004
612 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 19 0.0004
613 FEEDING DISORDER 8 0.0004
614 DEVICE BREAKAGE 16 0.0004
615 PYREXIA 136 0.0004
616 DRUG LEVEL DECREASED 4 0.0004
617 URINARY TRACT INFECTION 67 0.0004
618 SUBARACHNOID HAEMORRHAGE 4 0.0004
619 ACIDOSIS 3 0.0004
620 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
621 EUPHORIC MOOD 4 0.0004
622 MUSCLE TWITCHING 9 0.0004
623 LIP SWELLING 13 0.0004
624 EAR DISCOMFORT 4 0.0004
625 THYROID DISORDER 6 0.0004
626 OROPHARYNGEAL PAIN 36 0.0004
627 FLATULENCE 22 0.0004
628 MUSCULOSKELETAL CHEST PAIN 6 0.0004
629 ANKLE FRACTURE 6 0.0004
630 TOOTHACHE 7 0.0004
631 RASH GENERALISED 10 0.0004
632 HIATUS HERNIA 5 0.0004
633 INJECTION SITE INDURATION 5 0.0004
634 AMNESIA 25 0.0004
635 HYPERSOMNIA 11 0.0004
636 DIARRHOEA 247 0.0004
637 LETHARGY 22 0.0004
638 DERMATITIS 8 0.0004
639 HAEMATURIA 13 0.0004
640 BLOOD GLUCOSE ABNORMAL 7 0.0004
641 LIVER FUNCTION TEST ABNORMAL 11 0.0004
642 BLOOD ALBUMIN DECREASED 3 0.0004
643 INJECTION SITE REACTION 26 0.0004
644 SOPOR 5 0.0004
645 WEIGHT DECREASED 105 0.0004
646 OFF LABEL USE 329 0.0004
647 DRUG DOSE OMISSION 62 0.0004
648 BREAST CANCER FEMALE 10 0.0004
649 CONTUSION 36 0.0004
650 SENSORY DISTURBANCE 6 0.0004
651 QUALITY OF LIFE DECREASED 5 0.0004
652 PRESYNCOPE 9 0.0004
653 PRURITUS 142 0.0004
654 OEDEMA PERIPHERAL 45 0.0004
655 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
656 GINGIVAL BLEEDING 5 0.0004
657 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
658 LOWER LIMB FRACTURE 7 0.0004
659 COGNITIVE DISORDER 17 0.0004
660 HAEMATOCHEZIA 20 0.0004
661 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
662 EXPIRED PRODUCT ADMINISTERED 12 0.0004
663 BREAST CANCER STAGE II 3 0.0004
664 COUGH 101 0.0004
665 URINARY RETENTION 12 0.0004
666 COORDINATION ABNORMAL 5 0.0004
667 APHONIA 5 0.0004
668 BURNING SENSATION 25 0.0004
669 BLOOD CALCIUM DECREASED 4 0.0004
670 CHRONIC KIDNEY DISEASE 27 0.0004
671 BLINDNESS UNILATERAL 5 0.0004
672 EYE INFECTION 4 0.0004
673 STATUS EPILEPTICUS 4 0.0004
674 HYPERTENSION 75 0.0004
675 DISABILITY 7 0.0004
676 SINUS DISORDER 7 0.0004
677 MITRAL VALVE INCOMPETENCE 4 0.0004
678 DISORIENTATION 14 0.0004
679 HAEMATOCRIT DECREASED 7 0.0004
680 DYSGEUSIA 26 0.0003
681 EYE SWELLING 13 0.0003
682 BLOOD MAGNESIUM DECREASED 3 0.0003
683 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
684 PARAESTHESIA ORAL 5 0.0003
685 INTENTIONAL SELF-INJURY 7 0.0003
686 PRODUCT ADMINISTRATION ERROR 7 0.0003
687 RESPIRATORY TRACT INFECTION 9 0.0003
688 CYSTITIS 11 0.0003
689 INTESTINAL OBSTRUCTION 13 0.0003
690 ECZEMA 18 0.0003
691 POST PROCEDURAL HAEMORRHAGE 4 0.0003
692 INJECTION SITE PRURITUS 23 0.0003
693 JOINT STIFFNESS 9 0.0003
694 SOMNOLENCE 69 0.0003
695 DYSSTASIA 10 0.0003
696 HEART RATE DECREASED 12 0.0003
697 SPINAL PAIN 4 0.0003
698 CHILLS 40 0.0003
699 RIB FRACTURE 7 0.0003
700 DECREASED APPETITE 79 0.0003
701 DYSPNOEA 192 0.0003
702 LABORATORY TEST ABNORMAL 10 0.0003
703 CARDIOMYOPATHY 5 0.0003
704 OXYGEN SATURATION DECREASED 19 0.0003
705 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
706 CELLULITIS 17 0.0003
707 ATAXIA 4 0.0003
708 PULMONARY MASS 5 0.0003
709 IMMUNODEFICIENCY 5 0.0003
710 WRIST FRACTURE 4 0.0003
711 BLOOD POTASSIUM DECREASED 10 0.0003
712 OEDEMA 18 0.0003
713 UNEVALUABLE EVENT 25 0.0003
714 THERAPEUTIC RESPONSE DECREASED 20 0.0003
715 OSTEOPENIA 5 0.0003
716 HYPERSENSITIVITY 61 0.0003
717 JOINT INJURY 7 0.0003
718 CEREBRAL INFARCTION 8 0.0003
719 EYE PRURITUS 11 0.0003
720 AGITATION 24 0.0003
721 INJECTION SITE SWELLING 25 0.0003
722 INJECTION SITE URTICARIA 8 0.0003
723 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
724 CONDITION AGGRAVATED 99 0.0003
725 THERAPY INTERRUPTED 23 0.0003
726 HAIR COLOUR CHANGES 4 0.0003
727 ERYTHEMA 66 0.0003
728 PSORIATIC ARTHROPATHY 13 0.0003
729 PEMPHIGUS 4 0.0003
730 PERIPHERAL SWELLING 49 0.0003
731 PRODUCT USE COMPLAINT 5 0.0003
732 INFUSION RELATED REACTION 21 0.0003
733 COLITIS 12 0.0003
734 FOOT FRACTURE 6 0.0003
735 HALLUCINATION, AUDITORY 5 0.0003
736 PREMATURE DELIVERY 5 0.0003
737 OBESITY 5 0.0003
738 RASH PRURITIC 17 0.0003
739 ORAL PAIN 7 0.0003
740 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
741 CHOLESTASIS 6 0.0003
742 DEVICE ISSUE 28 0.0003
743 MYDRIASIS 4 0.0003
744 ATELECTASIS 3 0.0003
745 HERNIA 6 0.0003
746 INFLAMMATION 16 0.0003
747 CONSTIPATION 67 0.0003
748 DRY SKIN 41 0.0003
749 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
750 BODY TEMPERATURE DECREASED 3 0.0003
751 INCORRECT PRODUCT STORAGE 4 0.0003
752 ANKYLOSING SPONDYLITIS 4 0.0003
753 PRESCRIBED UNDERDOSE 6 0.0003
754 SYNCOPE 30 0.0003
755 SPINAL FRACTURE 6 0.0003
756 VISUAL IMPAIRMENT 37 0.0003
757 PERICARDITIS 5 0.0003
758 INJECTION SITE MASS 11 0.0003
759 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
760 STOMATITIS 18 0.0003
761 PRODUCT PRESCRIBING ERROR 7 0.0003
762 DEVICE EXPULSION 19 0.0003
763 DYSARTHRIA 11 0.0003
764 PRODUCT PREPARATION ERROR 6 0.0003
765 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
766 RHEUMATOID ARTHRITIS 33 0.0003
767 MUSCULAR WEAKNESS 33 0.0003
768 INFECTION 42 0.0003
769 PARANOIA 5 0.0003
770 DRUG INTERACTION 46 0.0003
771 LOSS OF CONSCIOUSNESS 37 0.0003
772 NERVOUS SYSTEM DISORDER 9 0.0003
773 PULMONARY HYPERTENSION 6 0.0003
774 MEDICATION ERROR 16 0.0003
775 NERVOUSNESS 15 0.0003
776 SPEECH DISORDER 15 0.0003
777 WITHDRAWAL SYNDROME 12 0.0003
778 SYRINGE ISSUE 5 0.0003
779 MOUTH ULCERATION 6 0.0003
780 SKIN REACTION 4 0.0003
781 INJECTION SITE ERYTHEMA 35 0.0003
782 ISCHAEMIC STROKE 5 0.0003
783 DRUG INTOLERANCE 27 0.0003
784 BLOOD CHOLESTEROL INCREASED 13 0.0003
785 HERPES ZOSTER 16 0.0003
786 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
787 FAECES DISCOLOURED 6 0.0003
788 ANOSMIA 4 0.0003
789 HAEMATEMESIS 7 0.0003
790 FLUID OVERLOAD 4 0.0003
791 BONE DISORDER 5 0.0003
792 APATHY 4 0.0003
793 PRODUCT STORAGE ERROR 24 0.0003
794 GASTROENTERITIS 4 0.0003
795 JOINT SWELLING 33 0.0003
796 RESTLESSNESS 10 0.0003
797 ANAPHYLACTIC REACTION 15 0.0003
798 EXPOSURE VIA SKIN CONTACT 7 0.0003
799 URINARY INCONTINENCE 8 0.0003
800 SKIN HAEMORRHAGE 4 0.0003
801 MALAISE 118 0.0003
802 PANCYTOPENIA 15 0.0003
803 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
804 PRODUCT USE ISSUE 50 0.0003
805 APHASIA 8 0.0003
806 MOBILITY DECREASED 19 0.0003
807 HEPATIC ENZYME INCREASED 18 0.0003
808 BLOOD COUNT ABNORMAL 4 0.0003
809 DYSPHAGIA 25 0.0003
810 GASTRIC ULCER 5 0.0003
811 RHINORRHOEA 17 0.0003
812 DEVICE FAILURE 4 0.0003
813 MUSCULOSKELETAL DISORDER 5 0.0003
814 MUSCULOSKELETAL STIFFNESS 23 0.0003
815 NEPHROLITHIASIS 12 0.0003
816 RASH 114 0.0003
817 SKIN DISCOLOURATION 12 0.0003
818 INJECTION SITE RASH 8 0.0003
819 DRUG INEFFECTIVE 343 0.0003
820 JAUNDICE 7 0.0003
821 ACUTE RESPIRATORY FAILURE 5 0.0003
822 OSTEOARTHRITIS 11 0.0003
823 LIMB DISCOMFORT 8 0.0003
824 NO ADVERSE EVENT 46 0.0003
825 DIVERTICULITIS 7 0.0003
826 ANAEMIA 48 0.0003
827 HYPOTHYROIDISM 8 0.0003
828 WOUND 7 0.0003
829 INJECTION SITE HAEMORRHAGE 20 0.0003
830 PRODUCT QUALITY ISSUE 34 0.0003
831 C-REACTIVE PROTEIN INCREASED 9 0.0002
832 TASTE DISORDER 5 0.0002
833 BACK DISORDER 4 0.0002
834 LUNG DISORDER 12 0.0002
835 IMPAIRED HEALING 8 0.0002
836 INJECTION SITE WARMTH 5 0.0002
837 PHOTOSENSITIVITY REACTION 4 0.0002
838 ARTHRITIS 19 0.0002
839 AGEUSIA 6 0.0002
840 SKIN DISORDER 8 0.0002
841 RHABDOMYOLYSIS 10 0.0002
842 GAIT INABILITY 8 0.0002
843 TYPE 2 DIABETES MELLITUS 8 0.0002
844 WHEEZING 14 0.0002
845 RESPIRATORY DISORDER 7 0.0002
846 GASTRIC DISORDER 8 0.0002
847 ACCIDENTAL EXPOSURE TO PRODUCT 24 0.0002
848 NEUROPATHY PERIPHERAL 22 0.0002
849 BLOOD GLUCOSE DECREASED 11 0.0002
850 EPILEPSY 7 0.0002
851 RASH MACULAR 8 0.0002
852 ANHEDONIA 6 0.0002
853 CONVULSION 13 0.0002
854 LYMPHOCYTE COUNT DECREASED 4 0.0002
855 TOOTH DISORDER 5 0.0002
856 GAIT DISTURBANCE 43 0.0002
857 BONE DENSITY DECREASED 7 0.0002
858 PANCREATITIS ACUTE 5 0.0002
859 HEAD INJURY 7 0.0002
860 AKATHISIA 3 0.0002
861 PRODUCT AVAILABILITY ISSUE 5 0.0002
862 UNDERDOSE 16 0.0002
863 DEVICE MECHANICAL ISSUE 3 0.0002
864 OSTEOPOROSIS 9 0.0002
865 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44 0.0002
866 INTENTIONAL PRODUCT MISUSE 19 0.0002
867 HYPOKALAEMIA 10 0.0002
868 CONJUNCTIVITIS 4 0.0002
869 SEPSIS 24 0.0002
870 HEPATIC STEATOSIS 4 0.0002
871 SUICIDE ATTEMPT 13 0.0002
872 BLISTER 12 0.0002
873 BLOOD TEST ABNORMAL 3 0.0002
874 SKIN EXFOLIATION 18 0.0002
875 ASTHENIA 80 0.0002
876 ANGINA PECTORIS 6 0.0002
877 ACUTE KIDNEY INJURY 32 0.0002
878 PULMONARY FIBROSIS 4 0.0002
879 PSORIASIS 27 0.0002
880 EMOTIONAL DISTRESS 25 0.0002
881 MENTAL IMPAIRMENT 5 0.0002
882 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
883 FALL 68 0.0002
884 ASCITES 6 0.0002
885 LIVER INJURY 5 0.0002
886 ACUTE MYOCARDIAL INFARCTION 6 0.0002
887 PULMONARY OEDEMA 9 0.0002
888 UPPER LIMB FRACTURE 4 0.0002
889 PREMATURE BABY 6 0.0002
890 GASTRIC CANCER 5 0.0002
891 DYSKINESIA 8 0.0002
892 DRUG ADMINISTRATION ERROR 6 0.0002
893 HYPOTENSION 39 0.0002
894 ANAPHYLACTIC SHOCK 5 0.0002
895 HAEMATOMA 5 0.0002
896 INCORRECT DOSE ADMINISTERED 44 0.0002
897 DRUG EFFECT INCOMPLETE 7 0.0002
898 PNEUMONIA 62 0.0002
899 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
900 CONFUSIONAL STATE 30 0.0002
901 EYE DISORDER 6 0.0002
902 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
903 RENAL FAILURE 24 0.0002
904 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
905 DEHYDRATION 24 0.0002
906 TRANSAMINASES INCREASED 4 0.0002
907 AGGRESSION 9 0.0002
908 HAEMOPTYSIS 5 0.0002
909 GLOSSODYNIA 4 0.0002
910 SKIN IRRITATION 8 0.0002
911 BALANCE DISORDER 15 0.0002
912 HALLUCINATION 13 0.0002
913 NEEDLE ISSUE 5 0.0002
914 RENAL DISORDER 8 0.0002
915 DEVICE USE ISSUE 3 0.0002
916 THROMBOCYTOPENIA 19 0.0002
917 HOSPITALISATION 26 0.0002
918 OCULAR HYPERAEMIA 8 0.0002
919 RENAL INJURY 5 0.0002
920 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
921 CEREBRAL HAEMORRHAGE 6 0.0002
922 FEMUR FRACTURE 5 0.0002
923 ANGIOEDEMA 7 0.0002
924 LIVER DISORDER 7 0.0002
925 DEVICE MALFUNCTION 11 0.0002
926 RENAL IMPAIRMENT 13 0.0002
927 DYSPHONIA 9 0.0002
928 ADVERSE EVENT 14 0.0002
929 DEVICE DIFFICULT TO USE 10 0.0002
930 RESPIRATORY FAILURE 11 0.0002
931 VISUAL ACUITY REDUCED 5 0.0002
932 CARDIAC FAILURE 12 0.0001
933 ILL-DEFINED DISORDER 9 0.0001
934 LIMB INJURY 4 0.0001
935 BLINDNESS 6 0.0001
936 NEUTROPHIL COUNT DECREASED 6 0.0001
937 SKIN LESION 4 0.0001
938 DELIRIUM 5 0.0001
939 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
940 APPLICATION SITE PAIN 3 0.0001
941 CEREBROVASCULAR ACCIDENT 23 0.0001
942 PSYCHOTIC DISORDER 4 0.0001
943 CARDIAC ARREST 11 0.0001
944 HEPATIC FAILURE 4 0.0001
945 APPLICATION SITE PRURITUS 3 0.0001
946 PLEURAL EFFUSION 8 0.0001
947 TINNITUS 6 0.0001
948 DIABETIC KETOACIDOSIS 3 0.0001
949 HIP FRACTURE 4 0.0001
950 EXTRA DOSE ADMINISTERED 5 0.0001
951 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
952 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
953 CARDIOVASCULAR DISORDER 3 0.0001
954 DEVICE LEAKAGE 5 0.0001
955 SEPTIC SHOCK 5 0.0001
956 PLATELET COUNT DECREASED 12 0.0001
957 DRUG EFFECT DECREASED 6 0.0001
958 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
959 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
960 ACCIDENTAL OVERDOSE 4 0.0001
961 INTENTIONAL OVERDOSE 7 0.0001
962 MYOCARDIAL INFARCTION 19 0.0001
963 ARTHROPATHY 6 0.0001
964 HYPONATRAEMIA 6 0.0001
965 ARRHYTHMIA 5 0.0001
966 HYPOGLYCAEMIA 5 0.0001
967 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
968 SKIN BURNING SENSATION 7 0.0001
969 RENAL FAILURE ACUTE 4 0.0001
970 HYPOACUSIS 4 0.0001
971 NEOPLASM MALIGNANT 6 0.0001
972 DEVICE USE ERROR 3 0.0001
973 CARDIAC DISORDER 8 0.0001
974 TREATMENT FAILURE 7 0.0001
975 COMA 4 0.0001
976 DRUG WITHDRAWAL SYNDROME 7 0.0001
977 BLOOD GLUCOSE INCREASED 15 0.0001
978 DIABETES MELLITUS 6 0.0001
979 BRADYCARDIA 4 0.0001
980 OVERDOSE 16 0.0001
981 DISEASE PROGRESSION 8 0.0001
982 NEUTROPENIA 9 0.0001
983 DRUG DOSE OMISSION BY DEVICE 5 0.0001
984 DRUG ABUSE 5 0.0001
985 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
986 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
987 BLOOD CREATININE INCREASED 3 0.0000
988 DRUG DEPENDENCE 7 0.0000
989 CARDIAC FAILURE CONGESTIVE 3 0.0000
990 DEATH 24 0.0000